Immunotherapy involves understanding and harnessing the relationship between the immune system and cancer cells to combat oncogenesis. There are many different potential immunotherapeutic approaches, including cell-based strategies such as adoptive cell transfer, receptor pathway-based strategies such as checkpoint inhibition, and agent-based approaches such as antibody therapy. Genetic engineering can be incorporated into all of these approaches. Gene editing can be used to modulate receptor expression levels, induce the production of certain molecules, change cellular phenotypes, or alter the general intensity of the immune response.
Evolution in the Manufacturing of Cellular TherapiesLessons learned and current solutions Immunotherapy is a powerful treatment that harnesses the body’s immune system in the fight against cancer. With optimized cell therapy, the result is an expanded population of T cells primed to recognize and eradicate malignant tumor cells that would otherwise escape immune detection. The webinar will discuss how cellular therapies have evolved, lessons learned through the evolution and current solutions available today. Learning Objectives: Commercialization of manufacturing- preparing a CAR Garage, lessons learned and how does it impact the patient. Automated functional testing- fully integrated unit operations taking the art out of science!